The Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS®) System is a prescription drug abuse, misuse and diversion surveillance system that collects timely product-and geographically-specific data.

 

The RADARS System measures rates of abuse, misuse and diversion throughout the United States, contributing to the understanding of trends and aiding the development of effective interventions. These data assist pharmaceutical companies in fulfillment of their regulatory obligations such as risk minimization action plans.

RADARS Website Graphic2.gif

The RADARS System includes:

þ     Multiple signal detection systems

þ     Multiple distinct features and services

þ     Prescription drug abuse, misuse and diversion rate calculation using two denominators:

o        Rates per 100,000 persons provide a community-based perspective of prescription drug abuse, misuse and diversion

o        Rates per 1,000 Unique Recipients of Dispensed Drug (URDD) accounts for availability of the prescribed product in a given community. This perspective addresses the needs of health care professionals and regulatory agencies such as the U.S. Food and Drug Administration

þ     Three-digit ZIP code level identification of location of prescription drug abuse, misuse and diversion

þ     Monitoring of 11 drug substances which include 77 products or subcategories, each of which may be reported on and additional drug substances can easily be added

þ     Standardized procedures and quality assurance practices ensuring the accuracy and integrity of data collection and reporting

þ     Experienced, expert analysis and consultation  

þ     Research for the benefit of the scientific community and the general public

 

News

News 2.gif

·         SAVE THE DATE! May 1, 2008--RADARS System Annual Scientific Meeting

 

·         The RADARS System Newsletter provides updates and announcements from the RADARS System. Visit the newsroom to subscribe.



Recent Publications

Cicero TJ, et al. The Development of a Comprehensive Risk-Management Program for Prescription Opioid Analgesics: Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS). Pain Medicine. 2007; 8: 157-170.

 

Hughes AA, et al. Reporting for the Researched Abuse Diversion and Addiction-Related Surveillance (RADARS®) System Poison Center Group. Active Surveillance of Abused and Misused Prescription Opioids Using Poison Center Data: A Pilot Study and Descriptive Comparison. Clinical Toxicology. 2007; 45:144-151.

 

Smith MY, et al. Quantifying Morbidity Associated with the Abuse and Misuse of Opioid Analgesics: A Comparison of Two Approaches. Clinical Toxicology. 2007; 45:23-30.

--View all Publications



History

The RADARS System was developed in 2002 by Purdue Pharma L.P. in response to increasing concerns of anticipated rates of prescription opioid abuse in the United States. In January 2006, the RADARS System became a non-profit operation of the Rocky Mountain Poison and Drug Center, a division of Denver Health and Hospital Authority. The RADARS System continues to grow and evolve in an effort to address new concerns and challenges as they arise. 



Privacy Statement  |  Terms Of Use
(c) 2006 RMPDC